Clinical Trial Update: Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pemetrexed disodium in combination with gemcitabine for stage IIIB/IV non-small cell lung cancer completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Mayo Clinic | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-13